Antibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Flow cytometry [1]
- Other assay [3]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-26879 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- GTSE1 Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- This antibody is predicted to react with mouse based on sequence homology.
- Reactivity
- Human
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 400 µL
- Concentration
- 0.27 mg/mL
- Storage
- Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Submitted references Downregulation of GTSE1 leads to the inhibition of proliferation, migration, and Warburg effect in cervical cancer by blocking LHDA expression.
Chen L, Zhong Y, Yang X, Zhang Q, Wu X
The journal of obstetrics and gynaecology research 2021 Nov;47(11):3913-3922
The journal of obstetrics and gynaecology research 2021 Nov;47(11):3913-3922
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Flow cytometry analysis of HeLa cells using a GTSE1 polyclonal antibody (Product # PA5-26879) (right) compared to a negative control cell (left) at a dilution of 1:10-50, followed by a FITC-conjugated goat anti-rabbit antibody
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- 1 FIGURE GTSE1 expression was elevated in cervical cancer tissues. (a) The mRNA levels of GTSE1 in 41 cervical cancer tissues and 30 normal cervical tissues were tested by RT-PCR (** p < 0.01). (b) IHC staining was carried out to assess the protein levels of GTSE1 in three cervical cancer tissues and three normal cervical tissues
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- 2 FIGURE Downregulation of GTSE1 impaired cell viability and migration in cervical cancer. (a) The protein levels of GTSE1 in SiHa, HeLa, CaSki, and C33A cells were determined by using western blotting assay. (b) The knockdown efficiency of shGTSE1 in SiHa and HeLa cells were determined by western blotting. (c) Colony formation assay was carried out for cell viability detection following cell infection with shNC or shGTSE1 in SiHa and HeLa cells. (d) CCK-8 assay was carried out to assess cell growth following cell infection with shNC or shGTSE1 in SiHa and HeLa cells. (e) Wound-healing assay was carried out for cell migration detection following cell infection with shNC or shGTSE1 in SiHa and HeLa cells. ( n = 3, p values were indicated in the figures)
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- 5 FIGURE Downregulation of GTSE1 inhibited in vivo tumor formation in cervical cancer cells. (a, b) Tumor size and volume induced by SiHa and HeLa cells. (c) The mRNA levels of LDHA in 41 cervical cancer tissues and 30 normal cervical tissues were tested by RT-PCR. (d, e) Western blotting and IHC assay were used to detect the expression of GTSE1, LDHA, and Ki67 in mice tumor tissues. The original western blot figures were shown in Supplementary File. ( n = 3, p values were indicated in the figures)